ColoWatch, Inc. /MD/
About ColoWatch, Inc. /MD/
ColoWatch® mission is to significantly expand the use of virtual colonoscopy (CT Colonography) for colorectal cancer prevention and screening. The company brings together clinical, business, and technical leaders committed to delivering reliable, standardized performance and interpretation of virtual colonoscopy studies. Over the last 25 years, virtual colonoscopy has been proven to be a highly accurate, extremely safe, convenient, and cost-effective method for colorectal cancer prevention and screening. It reliably detects clinically relevant polyps that are precursors to colorectal cancer and safely confirms the absence of disease in over 90% of scans.
- 🔗 About Us | ColoWatch®
- 🔗 Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations
- 🔗 MD Now Urgent Care - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 MD Urgent Care - 2026 Company Profile & Competitors - Tracxn
- 🔗 Health and Economic Benefits of Colorectal Cancer Interventions | National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) | CDC
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $975,000 in private placement funding.
- Focuses on expanding virtual colonoscopy (CT Colonography) adoption.
- Emphasizes standardized, reliable interpretation of screening studies.
- Targets colorectal cancer prevention with proven accurate and safe technology.
Ask StreetZero about ColoWatch, Inc. /MD/
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account